PharmaRoth Labs (PharmaRoth Labs) Interest Expense : $-0.01 Mil (TTM As of Mar. 2011)

View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. PharmaRoth Labs's interest expense for the three months ended in Mar. 2011 was $ -0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2011 was $-0.01 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. PharmaRoth Labs's Operating Income for the three months ended in Mar. 2011 was $ -0.10 Mil. PharmaRoth Labs's Interest Expense for the three months ended in Mar. 2011 was $ -0.00 Mil. PharmaRoth Labs did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

PharmaRoth Labs Interest Expense Historical Data

The historical data trend for PharmaRoth Labs's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaRoth Labs Interest Expense Chart

PharmaRoth Labs Annual Data

Trend

Jun08

Jun09

Jun10

Interest Expense

PharmaRoth Labs Quarterly Data
	Mar07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Interest Expense	Get a 7-Day Free Trial											-	-	-	-0.01	-

PharmaRoth Labs Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01 Mil.

PharmaRoth Labs (GREY:ROTH) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

PharmaRoth Labs's Interest Expense for the three months ended in Mar. 2011 was $-0.00 Mil. Its Operating Income for the three months ended in Mar. 2011 was $-0.10 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2011 was $0.00 Mil.

PharmaRoth Labs's Interest Coverage for the quarter that ended in Mar. 2011 is calculated as

PharmaRoth Labs did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

PharmaRoth Labs (PharmaRoth Labs) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117

Website

http://www.pharmaroth.com

PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines

From GuruFocus

Hotchkis and Wiley Value Opportunities Fund Buys Rothschild SCA, Oracle Corp, Medtronic PLC, Sells Amerco Inc, Anthem Inc, F5 Inc

By GuruFocusNews insider • 03-29-2022